EGFR and carcinoma: To further examine whether and how rapamycin and PP242 affect the EGFR pathway in the carcinoma cells, the colorectal carcinoma cell lines DLD-1 and HT29 were grown in 1% FBS culture medium containing 50 ng/ml of EGF.